Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Keiser

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Current Protocols in Mouse Biology|November 30, 2018
Adeno-Associated Virus Production, Purification, and TiteringYong Hong Chen, Megan S Keiser, Beverly L Davidson
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2014
Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapyMegan S Keiser, Ryan L Boudreau, Beverly L Davidson
Scandinavian Journal of Medicine & Science in Sports|May 7, 2015
Restoring heat stress-associated reduction in middle cerebral artery velocity does not reduce fatigue in the heatS Keiser, D Flück, A Stravs, et al.
Brain : a Journal of Neurology|October 23, 2015
Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapyMegan S Keiser, Jeffrey H Kordower, Pedro Gonzalez-Alegre, et al.
Molecular Therapy. Methods & Clinical Development|May 16, 2022
Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 miceEllie M Carrell, Megan S Keiser, Ashley B Robbins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In VivoAlex Mas Monteys, Shauna A Ebanks, Megan S Keiser, et al.
Annals of Neurology|October 1, 2016
RNAi prevents and reverses phenotypes induced by mutant human ataxin-1Megan S Keiser, Alejandro Mas Monteys, Romuald Corbau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2025
Current trends in gene therapy to treat inherited disorders of the brainZaneta Matuszek, Brandon L Brown, Carolyn M Yrigollen, et al.
Neurobiology of Disease|April 16, 2013
RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1Megan S Keiser, James C Geoghegan, Ryan L Boudreau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2023
Cochlear transduction via cerebrospinal fluid delivery of AAV in non-human primatesPaul T Ranum, Luis Tecedor, Megan S Keiser, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Current Protocols in Mouse Biology|November 30, 2018
Adeno-Associated Virus Production, Purification, and TiteringYong Hong Chen, Megan S Keiser, Beverly L Davidson
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 15, 2014
Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapyMegan S Keiser, Ryan L Boudreau, Beverly L Davidson
Scandinavian Journal of Medicine & Science in Sports|May 7, 2015
Restoring heat stress-associated reduction in middle cerebral artery velocity does not reduce fatigue in the heatS Keiser, D Flück, A Stravs, et al.
Brain : a Journal of Neurology|October 23, 2015
Broad distribution of ataxin 1 silencing in rhesus cerebella for spinocerebellar ataxia type 1 therapyMegan S Keiser, Jeffrey H Kordower, Pedro Gonzalez-Alegre, et al.
Molecular Therapy. Methods & Clinical Development|May 16, 2022
Combined overexpression of ATXN1L and mutant ATXN1 knockdown by AAV rescue motor phenotypes and gene signatures in SCA1 miceEllie M Carrell, Megan S Keiser, Ashley B Robbins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In VivoAlex Mas Monteys, Shauna A Ebanks, Megan S Keiser, et al.
Annals of Neurology|October 1, 2016
RNAi prevents and reverses phenotypes induced by mutant human ataxin-1Megan S Keiser, Alejandro Mas Monteys, Romuald Corbau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2025
Current trends in gene therapy to treat inherited disorders of the brainZaneta Matuszek, Brandon L Brown, Carolyn M Yrigollen, et al.
Neurobiology of Disease|April 16, 2013
RNAi or overexpression: alternative therapies for Spinocerebellar Ataxia Type 1Megan S Keiser, James C Geoghegan, Ryan L Boudreau, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 7, 2023
Cochlear transduction via cerebrospinal fluid delivery of AAV in non-human primatesPaul T Ranum, Luis Tecedor, Megan S Keiser, et al.
Pageof 6